Hideaki Mizutani

1.2k citations
25 papers · 579 indexed · h-index 9
Topics
Lung Cancer Treatments and Mutations (12 papers)Cancer Immunotherapy and Biomarkers (9 papers)Lung Cancer Research Studies (8 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Hideaki Mizutani

24 papers receiving 567 citations

Peers

Hideaki Mizutani
Comparison fields: 5 of 67
  • Molecular Biology 291
  • Cancer Research 225
  • Oncology 166
  • Pulmonary and Respiratory Medicine 144
  • Surgery 123
Replace Nayara Izabel Viana with:
Nayara Izabel Viana Brazil
Yexun Song China
Antonino Belfiore Italy
Shikai Zhu China
Tai‐Jan Chiu Taiwan
Patrick Tassone United States
Susrutha K. Wickremesekera New Zealand
Anna Fischer Germany
Piotr Hogendorf Poland
Mingxu Da China
Hideaki Mizutani relative to Nayara Izabel Viana Brazil Nayara Izabel Viana's profile →
Citations per field
00.5×1.5×
Nayara Izabel Viana · 1×
Citations per year

Countries citing papers authored by Hideaki Mizutani

Since Specialization
Citations

This map shows the geographic impact of Hideaki Mizutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Mizutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Mizutani more than expected).

Fields of papers citing papers by Hideaki Mizutani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Mizutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Mizutani. The network helps show where Hideaki Mizutani may publish in the future.

Co-authorship network of co-authors of Hideaki Mizutani

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Mizutani. A scholar is included among the top collaborators of Hideaki Mizutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Mizutani. Hideaki Mizutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 9
3 0
4 11
5 4
6 4
7 6
8 5
9 12
10 114
11 3
12 3
13 13
14 5
15 161
16 153
17
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer.
5
18 27
19 1
20 2

About Hideaki Mizutani

Hideaki Mizutani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 25 papers that have together received 579 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Cancer Research (225 citations), Oncology (166 citations) and Pulmonary and Respiratory Medicine (144 citations). Hideaki Mizutani has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masahiro Seike, Rintaro Noro, Akihiko Gemma, Yuji Minegishi, Kazuhiro Kitamura, Tetsuya Okano, Kuniko Matsuda, Akinobu Yoshimura, Chie Soeno and Akihiko Miyanaga. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026